Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

artemether / lumefantrine Oral Tablet [Coartem]

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Dried leaf Artemisia annua (DLA) has shown efficacy against Plasmodium sp. in rodent studies and in small clinical… Expand
  • figure 2
  • table 1
  • figure 1
2015
2015
BackgroundIn general, safety data following exposure to drugs in the first trimester of pregnancy are scarce. More specifically… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
2013
2013
BackgroundSafety surveillance of widely used artemisinin-based combination therapy (ACT) is essential, but tolerability data in… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Highly Cited
2009
Highly Cited
2009
BackgroundArtemether/Lumefantrine (Coartem®) has been used as a first-line treatment for uncomplicated Plasmodium falciparum… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Review
2009
Review
2009
Infants and children under five years of age are the most vulnerable to malaria with over 1,700 deaths per day from malaria in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Review
2009
Review
2009
Artemether and lumefantrine (AL), the active constituents of Coartem® exhibit complementary pharmacokinetic profiles. Artemether… Expand
  • table 1
  • figure 1
  • table 2
2008
2008
BackgroundNumerous trials have demonstrated high efficacy and safety of artemisinin-based combination therapy (ACT) under… Expand
  • table 1
  • table 2
  • table 3
2008
2008
BackgroundArtemether/lumefantrine (AL) has been adopted as the treatment of choice for uncomplicated malaria in Kenya and other… Expand
  • table 1
  • table 2
  • table 3
Highly Cited
2007
Highly Cited
2007
BackgroundIn view of the high level of chloroquine resistance in many countries, WHO has recommended the use of combination… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
2006
2006
BackgroundIn Zambia, unacceptably high resistance to commonly used antimalarial drugs prompted the choice of artemether… Expand
  • table 1
  • table 2
  • table 3